MA35742B1 - Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques - Google Patents

Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Info

Publication number
MA35742B1
MA35742B1 MA37145A MA37145A MA35742B1 MA 35742 B1 MA35742 B1 MA 35742B1 MA 37145 A MA37145 A MA 37145A MA 37145 A MA37145 A MA 37145A MA 35742 B1 MA35742 B1 MA 35742B1
Authority
MA
Morocco
Prior art keywords
antihelminthics
quinolinylmethyl
sulfonamide
derivatives
compounds
Prior art date
Application number
MA37145A
Other languages
English (en)
Inventor
George Philip Lahm
Moumita Kar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of MA35742B1 publication Critical patent/MA35742B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne des composés de formule 1, leurs
MA37145A 2011-11-28 2014-06-23 Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques MA35742B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161563926P 2011-11-28 2011-11-28
PCT/US2012/063802 WO2013081783A1 (fr) 2011-11-28 2012-11-07 Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Publications (1)

Publication Number Publication Date
MA35742B1 true MA35742B1 (fr) 2014-12-01

Family

ID=47179004

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37145A MA35742B1 (fr) 2011-11-28 2014-06-23 Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Country Status (20)

Country Link
US (1) US20140315857A1 (fr)
EP (1) EP2785694A1 (fr)
JP (1) JP2015502936A (fr)
KR (1) KR20140094026A (fr)
CN (1) CN103958476A (fr)
AR (1) AR089014A1 (fr)
AU (1) AU2012346433A1 (fr)
BR (1) BR112014012759A8 (fr)
CA (1) CA2855001A1 (fr)
CL (1) CL2014001377A1 (fr)
CO (1) CO6980661A2 (fr)
IL (1) IL232404A0 (fr)
MA (1) MA35742B1 (fr)
MX (1) MX2014006317A (fr)
PH (1) PH12014501181A1 (fr)
RU (1) RU2014126367A (fr)
SG (1) SG11201402664VA (fr)
TN (1) TN2014000166A1 (fr)
TW (1) TW201326128A (fr)
WO (1) WO2013081783A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014065411A1 (fr) * 2012-10-26 2014-05-01 株式会社エス・ディー・エス バイオテック Dérivé de sulfonamide utilisé comme agent de lutte contre les organismes nuisibles dans le domaine agricole/horticole
WO2014099837A1 (fr) * 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anti-helminthique
DK3538512T3 (da) * 2016-11-11 2021-07-05 Bayer Animal Health Gmbh Nye anthelmintiske quinolin-3-carboxamid-derivater
UA125800C2 (uk) * 2017-06-30 2022-06-08 Баєр Енімал Хелс Гмбх Похідні азахіноліну
EP4291555A1 (fr) * 2021-02-09 2023-12-20 Celgene Corporation Sulfamides et leur utilisation pour le traitement d'infections et de maladies helminthiques
US11905306B2 (en) 2021-12-21 2024-02-20 Southern Research Institute Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1815604A (en) 1922-10-31 1931-07-21 Winthrop Chem Co Organic mercury compound
US1679404A (en) 1926-02-04 1928-08-07 Rockwood Sprinkler Co Massachusetts Constant-alarm device for alarm valves
US1959705A (en) 1931-08-12 1934-05-22 Standard Steel Car Corp Car door
US5299582A (en) 1991-09-16 1994-04-05 Little Rapids Corporation Surgical isolation apparatus
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
ATE435648T1 (de) 1995-03-20 2009-07-15 Merck & Co Inc Derivaten von nodulisporen säure
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5595991A (en) 1995-03-20 1997-01-21 Merck & Co., Inc. Anthelmintic use of nodulisporic acid and analogs thereof
US5958888A (en) 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US5834260A (en) 1996-08-30 1998-11-10 Merck & Co., Inc. Antiparasitic agents
JP2003512290A (ja) 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6136838A (en) 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
US6239112B1 (en) 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
CA2411293A1 (fr) 1999-01-28 2000-07-28 Pfizer Products Inc. Nouveaux azalides et procede de fabrication
BRPI0017013B1 (pt) 2000-01-27 2015-07-14 Zoetis P Llc Composição de antibiótico azalídeo e método para sua obtenção
US6399796B2 (en) 2000-03-17 2002-06-04 Roche Vitamins Inc. Activation of a Diels-Alder reaction of a sterol 5,7-diene
KR20040091698A (ko) 2002-03-08 2004-10-28 쉐링-플라우 리미티드. 신규한 플로르페니콜형 항생제
US7388018B2 (en) * 2003-09-18 2008-06-17 Basf Aktiengesellschaft 4-Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents
JP4719160B2 (ja) 2003-12-23 2011-07-06 シェーリング−プラウ・リミテッド 改善された水溶性を有するフロルフェニコールプロドラッグ
WO2005066119A2 (fr) 2003-12-31 2005-07-21 Schering-Plough Ltd. 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols antibacteriens et procede de preparation de ces derniers
ATE362475T1 (de) 2003-12-31 2007-06-15 Schering Plough Ltd Bekämpfng von parasiten in tieren durch anwendung von imidazo(1,2-b)pyridazinderivaten
EP1571150A1 (fr) 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Procédé pour la prparation des inhibiteurs de tryptase
DE602005009381D1 (de) 2004-09-23 2008-10-09 Schering Plough Ltd Bekämpfung von parasiten in tieren durch verwendung neuer trifluormethansulfonanilidoximetherderivate
US7642391B1 (en) 2005-03-04 2010-01-05 Iowa State University Research Foundation, Inc. Palladium-catalyzed coupling of aryl halides with alkynes
AU2006224567A1 (en) 2005-03-16 2006-09-21 Basf Aktiengesellschaft Use of N- (4-pyridyl) methylsulfonamides for combating arthropodal pests
AR054380A1 (es) 2005-06-09 2007-06-20 Schering Plough Ltd Control de parasitos en animales con derivados de n- ((feniloxi) fenil) -1,1,1-trifluorometansulfonamida y de n-(fenilsulfanil) fenil) -1,1,1-trifluorometansulfonamida
US20070285554A1 (en) 2005-10-31 2007-12-13 Dor Givon Apparatus method and system for imaging
US20090069179A1 (en) * 2006-02-14 2009-03-12 Basf Se Pyridin-4-ylmethylamides
EA200801895A1 (ru) * 2006-03-15 2009-04-28 Басф Се Производные хинолина и их применение в качестве пестицидов
CA2655524A1 (fr) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Derives d'arylsulfonamidyl tetraline et leurs utilisations
JP2009542798A (ja) 2006-07-11 2009-12-03 ファイザー株式会社 置換ｎ−二環式アルキル二環式カルボキシアミド化合物
EA200900383A1 (ru) * 2006-09-12 2009-08-28 Басф Се Хинолинилметильные соединения
US8338455B2 (en) 2006-12-20 2012-12-25 Amgen Inc. Compounds and methods of use
WO2008090434A1 (fr) 2007-01-25 2008-07-31 Pfizer Japan Inc. Composés n-bicyclicalkyle bicyclique carboxyamide substitués
TWI482771B (zh) * 2009-05-04 2015-05-01 Du Pont 磺醯胺殺線蟲劑
AU2012273133A1 (en) * 2011-06-20 2013-11-07 E. I. Du Pont De Nemours And Company Heterocyclic compounds for treating helminth infections

Also Published As

Publication number Publication date
AR089014A1 (es) 2014-07-23
TN2014000166A1 (en) 2015-09-30
IL232404A0 (en) 2014-06-30
BR112014012759A8 (pt) 2017-06-20
AU2012346433A1 (en) 2014-05-08
CL2014001377A1 (es) 2014-10-17
CN103958476A (zh) 2014-07-30
RU2014126367A (ru) 2016-01-27
CA2855001A1 (fr) 2013-06-06
WO2013081783A1 (fr) 2013-06-06
BR112014012759A2 (pt) 2017-06-13
SG11201402664VA (en) 2014-06-27
PH12014501181A1 (en) 2014-09-08
CO6980661A2 (es) 2014-06-27
EP2785694A1 (fr) 2014-10-08
JP2015502936A (ja) 2015-01-29
TW201326128A (zh) 2013-07-01
US20140315857A1 (en) 2014-10-23
KR20140094026A (ko) 2014-07-29
MX2014006317A (es) 2014-06-23

Similar Documents

Publication Publication Date Title
MA37959A2 (fr) Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih
MA37142A3 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
MA35926B1 (fr) Pyrrolidine-2-carboxamides substitués
MA37519B1 (fr) Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
EA201590999A1 (ru) Пирролобензодиазепины и их конъюгаты
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
MA35905B1 (fr) Composés de bêta-lactame à substitution amidine, leur préparation et leur utilisation en tant qu'agents antibactériens
MA35089B1 (fr) Inhibiteurs de la production de leucotrienes de type benzodioxane
MA35357B1 (fr) Composes de type anilines
MA35086B1 (fr) Compose de triazolopyridine
MA35819B1 (fr) Composés hétéroaryl pyridones et aza-pyridones en tant qu'inhibiteurs de l'activité btk
MA34963B1 (fr) Derives de fluoro-pyridinone utiles en tant qu'agents antibacteriens
MA38645A1 (fr) Nouveaux inhibiteurs de cyp17/antiandrogènes
TR201900038T4 (tr) GPR6'nın tetrahidropiridopirazin modülatörleri.
MA35742B1 (fr) Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
EA201590854A1 (ru) Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2
CR20130501A (es) Derivados novedosos de cefalosporinas y composiciones farmacéuticas de estos
UA107455C2 (uk) Похідні індолу як протиракові агенти
EA201791321A1 (ru) Составы ингибитора lfa-1
CR20140322A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
TR201902057T4 (tr) Tetrasiklin bileşikleri.
MA40250A (fr) Dérivés de quinolizinone utilisés comme inhibiteurs de pi3k
MA34578B1 (fr) Composés de tétrahydrofuranyl disubstitués en tant qu'antagonistes du récepteur de la bradykinine b1